| Literature DB >> 35871425 |
Babak Arjmand1, Bagher Larijani2, Sepideh Alavi-Moghadam3, Hamid Reza Aghayan3, Mostafa Rezaei-Tavirani4, Parisa Goodarzi3, Akram Tayanloo-Beik3, Mahmood Biglar5, Mohsen Rajaeinejad6, Fatemeh Fazeli Shouroki3.
Abstract
The field of regenerative medicine (RM) as an innovative technology has the ability to affect the healthcare system. It develops a variety of techniques through stem cell biology, genetics, bioengineering, biomaterial science, and tissue engineering to replace or restore the role of lost, disabled, or aging cells in the human body. However, the field's proficiency has still been underwhelming at the clinical trial level. This could be due to the innovation of such technologies, as well as their incredible nature. Therefore, managing the infrastructure framework for the safe and efficient application of the aforementioned field of science would help in the process of progress. In this context, the current review focuses on how to establish infrastructures for more effective RM.Entities:
Keywords: Cell- and tissue-based therapy; Marketing of health services; Regenerative medicine
Year: 2022 PMID: 35871425 DOI: 10.1007/s10561-022-10028-2
Source DB: PubMed Journal: Cell Tissue Bank ISSN: 1389-9333 Impact factor: 1.752